Internalization and degradation of HER2 receptor protein Western blot showed that trastuzumab (1 µmol/l for 4 days) downregulated HER2 protein in SKBR3 and MDA453 cells [98] 2B1 Bispecific ...
*p < 0.001; **p < 0.0001; ***p = 0.01; ****p < 0.01 vs comparator regimen.CClR: Cyclophosphamide + cladribine + rituximab; ClR: Cladribine + rituximab; CR: Complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback